NOEBTRI
Regeneron Pharmaceuticals, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88813361 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Terrence J. McAllister |
| Attorney Docket Number | 554.1685UST1 |
Timeline
| 2020-02-27 | Application Filed |
| 2020-03-05 | Location: NEW APPLICATION PROCESSING |
| 2020-03-05 | Status: Live/Pending |
| 2020-03-05 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Regeneron Pharmaceuticals, Inc. |
| Address | 777 Old Saw Mill River Road Tarrytown NY 10591 |
| Legal Entity Type | Corporation |
| Legal Entity State | NY |
Documents
 Application | MULTI | 2020-02-27 |
 Drawing | JPEG | 2020-02-27 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for treatment or prevention of Ebola virus infections; antivirals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-05 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-05-17 | 2 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-22 | 3 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-06-10 | 4 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-06-30 | 5 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-30 | 6 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-08-25 | 7 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-02-09 | 8 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2021-02-09 | 9 EXT1 S: |
| EXTENSION 1 GRANTED | 2021-02-09 | 10 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-02-11 | 11 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-08-05 | 12 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2021-08-05 | 13 EXT2 S: |
| EXTENSION 2 GRANTED | 2021-08-05 | 14 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-08-07 | 15 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-01 | 16 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-02-08 | 17 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2022-02-01 | 18 EXT3 S: |
| EXTENSION 3 GRANTED | 2022-02-08 | 19 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-09 | 20 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-07-14 | 21 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-07-14 | 22 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-07-14 | 23 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2022-07-19 | 24 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2022-07-19 | 25 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2022-07-19 | 26 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-07-21 | 27 EXRA E:E-Mail |
| ASSIGNED TO EXAMINER | 2023-01-12 | 28 DOCK D:Assigned to Examiner |
| TEAS EXTENSION RECEIVED | 2023-01-30 | 29 EEXT I:Incoming Correspondence |
| SOU EXTENSION 5 FILED | 2023-01-30 | 30 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2023-02-06 | 31 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-07 | 32 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2023-09-25 | 33 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2023-09-25 | 34 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NOEBTRI 97509973 not registered Live/Pending |
Regeneron Pharmaceuticals, Inc. 2022-07-19 |
 NOEBTRI 88813369 not registered Live/Pending |
Regeneron Pharmaceuticals, Inc. 2020-02-27 |
 NOEBTRI 88813361 not registered Live/Pending |
Regeneron Pharmaceuticals, Inc. 2020-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 